<DOC>
	<DOC>NCT01436903</DOC>
	<brief_summary>CavatermTM is a second-generation thermal balloon ablation device in the management of menorrhagia. The purpose of this study is to investigate the success (questionnaire) of CavatermTM dependent on uterus probe length, especially corpus probe length, which is measured during surgery.</brief_summary>
	<brief_title>Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length</brief_title>
	<detailed_description />
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>CavatermTM operation because of menorrhagia timeframe: January 2006 till August 2009 older than 29 years and younger than 56 years pregnancy fragmentary filled questionnaire more than 1 CavatermTM operation</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>menorrhagia</keyword>
	<keyword>dysfunctional uterine bleeding</keyword>
	<keyword>endometrial ablation</keyword>
	<keyword>cavatermTM</keyword>
	<keyword>probe</keyword>
</DOC>